|
Market Closed -
Nasdaq
04:00:00 2026-04-16 pm EDT
|
5-day change
|
1st Jan Change
|
|
5.000 USD
|
-3.66%
|
 |
+12.61%
|
-18.70%
|
|
Mar. 16 |
Veracyte Appoints Kevin Haas as Chief Development and Technology Officer
|
MT
| |
Mar. 16 |
Veracyte, Inc. Appoints Kevin Haas as Chief Development and Technology Officer, Effective March 24, 2026
|
CI
| |
Feb. 27 |
Myriad Genetics Insider Bought Shares Worth $494,722, According to a Recent SEC Filing
|
MT
| |
25-10-30 |
Neogen® Corporation Announces the Appointment of Bryan Riggsbee as Its Senior Vice President, Effective November 3, 2025
|
CI
| |
25-10-03 |
Myriad Genetics, Inc. Announces Executive Changes, Effective October 24, 2025
|
CI
| |
25-08-18 |
Myriad Genetics appoints Ben Wheeler chief financial officer
|
RE
| |
25-08-18 |
Myriad Genetics Names Ben Wheeler CFO
|
MT
| |
25-04-07 |
Myriad Genetics, Inc. Appoints Brian Donnelly as Chief Commercial Officer, Effective May 1, 2025
|
CI
| |
25-02-25 |
Myriad Genetics Appoints Sam Raha as Chief Executive
|
MT
| |
25-02-24 |
Myriad Genetics Appoints Sam Raha As President And CEO
|
RE
| |
25-02-24 |
Myriad Genetics, Inc. Announces Chief Executive Officer Changes
|
CI
| |
25-02-24 |
Myriad Genetics, Inc. Announces Management Changes
|
CI
| |
24-12-10 |
Myriad Genetics Elects Mark S. Davis as New Board Member
|
CI
| |
24-11-19 |
Sintx Technologies, Inc. Appoints Gregg R. Honigblum as Chief Strategy Officer
|
CI
| |
24-09-12 |
Myriad Genetics Insider Sold Shares Worth $400,800, According to a Recent SEC Filing
|
MT
| |
24-09-09 |
Myriad Genetics Insider Sold Shares Worth $270,520, According to a Recent SEC Filing
|
MT
| |
24-09-05 |
Myriad Genetics Insider Sold Shares Worth $1,285,851, According to a Recent SEC Filing
|
MT
| |
24-07-31 |
Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer, Effective September 3, 2024
|
CI
| |
24-01-31 |
Myriad Genetics Names George Daneker Jr. as President, Chief Clinical Officer of Oncology
|
MT
| |
24-01-30 |
Myriad Genetics, Inc. Appoints George Daneker as President and Chief Clinical Officer of Oncology, Effective March 18, 2024
|
CI
| |
23-12-21 |
Myriad Genetics Names Scott Leffler as Chief Financial Officer, Reiterates Outlook
|
MT
| |
23-11-03 |
Myriad Genetics Insider Sold Shares Worth $470,622, According to a Recent SEC Filing
|
MT
| |
23-11-01 |
Myriad Genetics Names Sam Raha as Chief Operating Officer
|
MT
| |
23-11-01 |
Myriad Genetics, Inc. Appoints Samraat S. Raha as Chief Operating Officer, Effective as of December 11, 2023
|
CI
| |
23-10-05 |
Myriad Genetics COO Nicole Lambert to Step Down
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
